Hepatitis C Virus and Cytokine Responses

Similar documents
HHS Public Access Author manuscript Gastroenterology. Author manuscript; available in PMC 2015 June 24.

Intrinsic cellular defenses against virus infection

Reduced Antibody Responses to the Pandemic (H1N1) 2009 Vaccine after Recent Seasonal Influenza Vaccination

Antiviral Chemotherapy

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Viral Evasion Strategies

Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis

Apoptosis in chronic hepatitis C

Immunity to Viruses. Patricia Fitzgerald-Bocarsly September 25, 2008

Anti-infectious Immunity

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Alcoholic hepatitis is a drug-induced disorder

Basis and Clinical Applications of Interferon

IMMUNE EVASION STRATEGIES OF HEPATITIS C VIRUS

Hepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B

Patricia Fitzgerald-Bocarsly

Liver Cancer. Su Jong Yu, M.D. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine

Dynamic Interaction of Stress Granule, DDX3X and IKK-α Mediates Multiple Functions in

Supplementary Information

Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients

Hepatitis B Virus infection: virology

Tumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)

Hepatitis B New Therapies

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

New Drug Research for Chronic Hepatitis B Man-Fung Yuen, MD, PhD

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation

Effector Mechanisms of Cell-Mediated Immunity

T Cell Activation, Costimulation and Regulation

Interferon- induction and related signaling pathways in human hepatocyte cell lines

Emerging Viruses. Part IIb Follow Up from Part I Vaccines and Inhibitors

Cross-regulation of host STATs for the survival of Toxoplasma gondii

2017 Obesity Fact Sheet

Hepatitis C wi w t i h Ju J dy y W y W a y t a t t

Oncolytic virus strategy

Role of Innate Immunity in Hepatitis B Virus Infection Adam J. Gehring, Ph.D.

Supplementary Information

The Immune Response of Prolactin and the Induction of Tumor Necrosis Factor (TNF) in Iraqi Patients Infected with Hepatitis C Virus.

Quality of life (QoL) in metastatic breast cancer patients with. maintenance paclitaxel plus gemcitabine (PG) chemotherapy:

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Seung Hyeok Han, MD, PhD Department of Internal Medicine Yonsei University College of Medicine

HCV eradication with direct acting antivirals (DAAs)? Why is viral cure possible in HCV? Emilie Estrabaud

Learning Objectives: Hepatitis Update. Primary Causes of Chronic Liver Disease in the U.S. Hepatitis Definition. Hepatitis Viruses.

Correspondence should be addressed to Shilin Li; and Limin Chen; limin chen

Innate-like Cytotoxic Function of Bystander- Activated CD8 + T Cells Is Associated with Liver Injury in Acute Hepatitis A

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

IMMU3903 Immunology in Human Disease 2017

Hepatitis B virus (HBV) is a major public health

Immune surveillance hypothesis (Macfarlane Burnet, 1950s)

Hepatitis B. What's the impact on the risk? Dr Himanshu Bhatia, Asia Chief Medical Officer ALUCA, Brisbane, Sept 2013

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

T Lymphocyte Activation and Costimulation. FOCiS. Lecture outline

The role of Hepatitis C Virus in hepatocarcinogenesis

Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance

Original article Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

The current recommended therapy for chronic

New Drug Development for Hepatic Insulin Resistance

MF Yuen 2, CS Coffin 3, M Elkhashab 4, S Greenbloom 5, A Ramji 6, H LY Chan 7, RP Iyer 1, S Locarnini 8, C Macfarlane 1, NH Afdhal 1, W Kim 9

The Adaptive Immune Responses

Emerging Need for Vaccination against Hepatitis A Virus in Patients with Chronic Liver Disease in Korea

Structure and Function of Antigen Recognition Molecules

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

Engineered Immune Cells for Cancer Therapy : Current Status and Prospects

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics

AGAINST VIRAL INFECTIONS. Identify the types of immunity involve in the mechanisms of protection against viral infections.

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Disclosures. No conflict of interest. van der Ree, AASLD

Newly Recognized Components of the Innate Immune System

This is a free sample of content from The Hepatitis B and Delta Viruses. Click here for more information on how to buy the book.

Inarigivir ACHIEVE Trial Results and HBV Clinical Program Update. August 2, 2018

NOTES. The Naturally Attenuated Kunjin Strain of West Nile Virus Shows Enhanced Sensitivity to the Host Type I Interferon Response

Hepatitis B. HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, Lalo Flores, PhD Global Head HBV R&D

La riattivazione dell epatite virale nel paziente in terapia biologica

Alla ricerca del virus nascosto (quando il virus dell epatitie B si occulta )

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

CELL BIOLOGY - CLUTCH CH CANCER.

silent epidemic,. (WHO),

Lecture on Innate Immunity and Inflammation

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION

Innate immunity. Abul K. Abbas University of California San Francisco. FOCiS

Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitors

IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal

Practical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen

Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition

THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV

Immune response to infection

10th International Rotavirus Symposium Bangkok, Thailand

Title Page. Viral Exploitation of Host SOCS Protein Functions. Lisa Nowoslawski Akhtar and Etty N. Benveniste

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

Curriculum Vitae (Last updated: ) Jin-Gu Lee, PhD

Hyun Kee Kim, M.S. Curriculum Vitae

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

Development of a Conditional Replication Competent Adenovirus, Controlled by the Human Telomerase Promoter (htert)

Intron A Hepatitis B. Intron A (interferon alfa-2b) Description

Shiv Pillai Ragon Institute, Massachusetts General Hospital Harvard Medical School

Antiviral agents in HCV

Transcription:

Hepatitis C Virus and Cytokine Responses Eui-Cheol Shin, M.D., Ph.D. Laboratory of Immunology & Infectious Diseases (LIID), Graduate School of Medical Science & Engineering (GSMSE), KAIST Daejeon, Korea ecshin@kaist.ac.kr

Hepatitis C Virus (HCV) Infection 1. Worldwide, 170 million people are infected. 2. After acute infection, 60-80% of patients develop persistent infection. 3. Chronic persistent infection progresses to liver cirrhosis and hepatocellular carcinoma. 4. HCV modulates cytokine responses of host cells.

The HCV cell culture (HCVcc) system

1. TNF response 2. IFN response

HCV Infection Sensitizes Cells to TNF- -Induced Cell Death Park J & Kang W et al. Hepatology 2012, 56:831

HCV Infection Suppresses TNF- -Induced NF- B Activation SP600125: JNK inhibitor SN50: NF- B inhibitor Park J & Kang W et al. Hepatology 2012, 56:831

HCV Infection Suppresses TNF- -Induced Expression of Anti-Apoptotic Proteins Park J & Kang W et al. Hepatology 2012, 56:831

HCV Core, NS4B, and NS5B Inhibit TNF- -Induced NF- B Activation Park J & Kang W et al. Hepatology 2012, 56:831

Summary (1) Park J & Kang W et al. Hepatology 2012, 56:831

1. TNF response 2. IFN response

CD8 + T cells and MHC class I CD8 + T cells often fail to eradicate HCV infection. CD8 + T cells recognize virus-infected cells by detecting viral peptides presented on MHC class I molecules. Many viruses evade CD8 + T cell responses by downregulating MHC class I expression on virus-infected cells. CD8 + T cell TCR MHC class I Peptide HCV-infected hepatocyte

HCV infection attenuates IFN-induced MHC class I upregulation IFN- / IFN- Kang W et al. Gastroenterology 2014, 146:1351

HCV infection attenuates IFN-induced MHC class I upregulation MHC class I Control IFN- IFN- Kang W et al. Gastroenterology 2014, 146:1351

HCV protein expression does not lead to attenuation of IFN-induced MHC-I upregulation Kang W et al. Gastroenterology 2014, 146:1351

HCV infection reduces synthesis rate of MHC class I protein Protein synthesis rate Kang W et al. Gastroenterology 2014, 146:1351

HCV infection phosphorylates PKR and eif2 Garaigorta U & Chisari FV. Cell Host & Microbe 6:513, 2009 HCV blocks IFN- / -induced ISG production by inducing PKR phosphorylation. Kang W et al. Gastroenterology 2014, 146:1351

PKR silencing restores IFN-induced MHC class I expression Kang W et al. Gastroenterology 2014, 146:1351

Summary (2) HCV infection attenuates IFN-induced MHC class I expression at translational level through activation of the PKR-eIF2 pathway; not by blocking IFN signaling or mrna transcription. This leads to a reduction of the antiviral effector functions of HCV-specific CD8 + T cells. Herein, we suggest a novel mechanism by which HCV circumvents antiviral adaptive immune responses. HCV infection Replicating HCV RNA Activation of PKR-eIF2α pathway Attenuation of IFNinduced MHC class I protein synthesis Reduced antiviral effector functions of HCV-specific CD8 + T cells Immune evasion Kang W et al. FP-61 (6/13,16:30)

Antigen-Processing & Presentation for CD8 T Cells Kloetzel. 2001 Nat Rev Mol Cell Biol 2:179

Induction of Immunoproteasome by IFNs Constitutive proteasome Immunoproteasome Viral infection T cells / NK cells IFN- Type I IFN LMP2 LMP7 MECL1 1. Immunoproteasome generates peptides more efficiently. 2. Immunoproteasome generates peptides which cannot be generated by constitutive proteasome. immunoproteasome-dependent peptides

Number of cells (%) HCV infection attenuates IFN-stimulated immunoproteasome induction Uninfected Huh-7.5 JFH1 infected Huh-7.5 79.6 HCV core Oh IS et al. FP-22 (6/12,16:30)

Acknowledgments Laboratory of Immunology & Infectious Diseases (LIID), Graduate School of Medical Science & Engineering (GSMSE), KAIST Daejeon, Korea Wonseok Kang, Pil Soo Sung, In Soo Oh, Dong-Yeop Chang Department of Microbiology, Ajou University School of Medicine, Suwon, Korea Sarah Yoon, Yong-Joon Chwae Liver Diseases Branch, NIDDK, National Institutes of Health, Bethesda, MD, USA Su-Hyung Park, Barbara Rehermann Department of Internal Medicine, Yonsei University School of Medicine, Seoul, Korea Seungtaek Kim, Ja Kyung Kim, Kwang Hyub Han Department of Bio & Brain Engineering, KAIST, Daejeon, Korea Junseong Park, Seung-Wook Ryu, Kyungsun Choi, Chulhee Choi Department of Pathology, Pusan National University Hospital, Busan, Korea Do Youn Park Department of Physiology, Ewha Womans University School of Medicine, Seoul, Korea Youn-Hee Choi

IFN Signaling Nat Rev Immunol 2005, 5:375

ISGF3 components are overexpressed without phosphorylation in HCV-infected livers Healthy liver HCV infected liver HCV-infected Huh-7-TLR3 + IFN- STAT1 pstat1 STAT2 IRF9 Actin Healthy liver HBV-infected liver Huh-7-TLR3 + IFN- STAT1 pstat1 STAT2 IRF9 Actin Sung PS et al. FP-61 (6/13,16:30)